M&A TRANSACTION · 2024
Fior & Gentz acquired by Össur
$120.0M· 17.4x EBITDA· 5.20x revenue
Target
Fior & Gentz
Acquirer
Össur
Strategic buyer
Disclosed financials at time of acquisition
Revenue
$23.0M
EBITDA
$6.9M
Deal Value
$120.0M
EV/EBITDA
17.4x
Context
This $120.0M acquisition of Fior & Gentz by Össur sits in the medical devices sub-vertical. The 17.4x EBITDA multiple paid in 2024 can be compared against the population median for medical devices transactions of similar size on our Medical Devices valuation hub. Össur is acquiring as a strategic buyer; see how strategic acquirers typically price medical devices businesses on our Medical Devices strategic buyer-pool page.
Source
Data sourced from Press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own medical devices
Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.
Compare your business to the Fior & Gentz acquisition.